- Home
- » Tags
- » Solifenacin
Top View
- Drug-Induced Hyperhidrosis and Hypohidrosis Incidence, Prevention and Management
- Overactive Bladder Jack Barkin, MD Humber River Regional Hospital, University of Toronto, Toronto, Ontario, Canada
- Management of Incontinence in Older Adults*
- Comparative Characterization of Lung Muscarinic Receptor Binding After Intratracheal Administration of Tiotropium, Ipratropium, and Glycopyrrolate
- Vesicare® Gastrointestinal Motility (5.3) Safely and Effectively
- VESICARE (Solifenacin Succinate) Tablets, for Oral Use Gastrointestinal Disorders: Vesicare Is Not Recommended for Use in Initial U.S
- Trospium Chloride Transport by Mouse Drug Carriers of the Slc22 and Slc47 Families
- Medication and Falls Risk Classification Guide
- Medication for Overactive Bladder
- Solifenacin 5 Mg Film-Coated Tablets
- Use of Overactive Bladder Medications in the Adult Population Of
- Bladder Relaxant Preparations
- Drug Class Review on Agents for Overactive Bladder
- Recommendation from the New Drugs Committee
- Medicines and Falls in Hospital
- Neemmc Guidelines for Tablet Crushing and Administration Via Enteral Feeding Tubes
- Diphenhydramine (E.G., Benadryl)
- 372 Fesoterodine Is Cost-Effective Relative To
- Anticholinergic Drugs and Dementia
- Report and Evidence Tables
- List of Drugs to Be Avoided by Patients with Congenital Long QT Syndrome
- Solifenacin Succinate
- Overactive Bladder Pathway
- Solifenacin (VESICARE) Vs Oxybutynin (DITROPAN) Vs Placebo 1 Use in Elderly People with Mild Cognitive Impairment (MCI)
- Myrbetriq (Mirabegron)
- 399 Svt-40776, Solifenacin, Darifenacin And
- QT Prolongation
- Scientific and Regulatory Reasons for Delay and Denial of FDA Approval of Initial Applications for New Drugs, 2000-2012
- Comparison of Two Selective Muscarinic Receptor Antagonists (Solifenacin and Darifenacin) in Women with Overactive Bladder – the SOLIDAR Study
- Fesoterodine Is Cost-Effective Relative to Tolterodine And
- Solifenacin Shows Superior Tolerability Compared To
- Management of Overactive Bladder in Adults
- 89 Comparison of Solifenacin 5 Mg and Tolterodine Er 4 Mg in the Star Oab Study
- MANAGEMENT of URINARY INCONTINENCE and OVERACTIVE BLADDER No 3, Nov 2015 Produced by NHS Greater Glasgow and Clyde Medicines Information Service
- Solifenacin, Darifenacin and Trospium for Overactive Bladder: Guidelines, Clinical and Cost-Effectiveness
- Trial of Stopping Your Overactive Bladder Drug
- OAB) Syndrome
- Treatment of Urinary Incontinence • Tolterodine 2Mg BD (Or Neditol MR 4Mg
- Overactive Bladder in the Elderly a Guide to Pharmacological Management
- Pharmacological Treatment of Urinary Incontinence
- Alcohol, Medications, and Older Adults Mailtreyee Mohanty Virginia Commonwealth University
- Comparison of Side Effects of Solifenacin Vs Tolteridine in Patients with Urinary Incontinence
- Table of Medications That Increase Fall Risk
- Comparison of Solifenacin and Fesoterodine in Treatment of Overactive Bladder
- Medicines and Falls – Guidance on Causes and Risks (Version 1 – July 2015)
- Treatment of Overactive Bladder